Cobblestone Capital Advisors LLC Rocket Pharmaceuticals, Inc. Transaction History

Cobblestone Capital Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$16.78 - $31.94 $151,020 - $287,460	9,000 New	9,000 $269,000
Q4 2021 Feb 11, 2022	SELL	$21.52 - $36.02 $193,680 - $324,180	-9,000 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$27.42 - $48.97 $246,780 - $440,730	-9,000 Reduced 50.0%	9,000 $269,000
Q2 2018 Aug 03, 2018	BUY	$14.58 - $23.0 $262,440 - $414,000	18,000 New	18,000 $0

244

108M

262K

159K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $663M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Cobblestone Capital Advisors LLC , based on Form 13F filings with the SEC.

Stay updated on Cobblestone Capital Advisors LLC with notifications on news.